BMC Cancer

1. NIKKILA R, Hirvonen E, Haapaniemi A, Pitkaniemi J, et al
   Second primary cancers in patients with a pharyngeal index tumour: a register-based cohort study.
   BMC Cancer. 2024;24:1380.
   

   >> Share

   
   
2. YANG Y, Zhang J, Yuan C, Cheng Z, et al
   Recurrent aphthous stomatitis and neoplasms of the mouth and pharynx: a two-sample Mendelian randomization study.
   BMC Cancer. 2024;24:1372.
   

   >> Share

   
   
3. PAN C, Ng K, Voutsinas J, Barber B, et al
   Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
   BMC Cancer. 2024;24:1406.
   

   >> Share

   
   
4. ZHOU Y, Zhou J, Cai X, Ge S, et al
   Integrating (18)F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer.
   BMC Cancer. 2024;24:1402.
   

   >> Share

   
   

   
   Br J Cancer

5. EKSTEDT S, Piersiala K, Kolev A, Farrajota Neves da Silva P, et al
   Phenotypical differences of neutrophils patrolling tumour-draining lymph nodes in head and neck cancer.
   Br J Cancer. 2024 Nov 14. doi: 10.1038/s41416-024-02891.
   

   >> Share

   
   

   
   Cancer

6. ABYANEH R, Ghalehtaki R, Sanford NN
   Combination of immune checkpoint inhibitors and radiotherapy in locally advanced esophagogastric junction adenocarcinoma: A review.
   Cancer. 2024;130:4040-4051.
   

   >> Share

   
   
7. NIERENGARTEN MB
   Promising long-term disease control and survival with pembrolizumab and cabozantinib for head and neck cancer.
   Cancer. 2024;130:3947.
   

   >> Share

   
   
8. NIERENGARTEN MB
   Increased head and neck cancer linked to cannabis use.
   Cancer. 2024;130:3946.
   

   >> Share

   
   

   
   Clin Cancer Res

9. WANG X, Kang X, Zhang R, Xue L, et al
   Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial.
   Clin Cancer Res. 2024;30:5061-5072.
   

   >> Share

   
   
10. LI Q, Zhang W, Liao T, Gao Y, et al
    An AI-driven preoperative radiomic subtype for predicting the prognosis and treatment response of patients with papillary thyroid carcinoma.
    Clin Cancer Res. 2024 Nov 13. doi: 10.1158/1078-0432.CCR-24-2356.
    

    >> Share

    
    

    
    Dis Esophagus

11. LIU C, Lan TL, Tsai PC, Chien LI, et al
    Managing esophageal squamous cell carcinoma after cervical radiotherapy for a head and neck cancer: esophagectomy remains a viable option.
    Dis Esophagus. 2024 Nov 7:doae099. doi: 10.1093.
    

    >> Share

    
    

    
    Gastrointest Endosc

12. FUJIYOSHI Y, Khalaf K, He T, Tham D, et al
    Comparison of EMR versus endoscopic submucosal dissection for Barrett's neoplasia and esophageal adenocarcinoma: a systematic review and meta-analysis.
    Gastrointest Endosc. 2024;100:817-828.
    

    >> Share

    
    
13. MOHAPATRA S, Al Ghamdi SS, Charilaou P, Lopimpisuth C, et al
    Predictors for lymph node metastasis and survival of patients with T1b esophageal adenocarcinoma treated with surgery and endoscopic therapy: an analysis of the Surveillance, Epidemiology, and End Results database.
    Gastrointest Endosc. 2024;100:849-856.
    

    >> Share

    
    

    
    Head Neck

14. SUTTER OP, Maurer A, Stadler TM, Lanzer M, et al
    Recurrence Detection by Hybrid [(18)F]FDG-PET in Advanced Head and Neck Squamous Cell Carcinoma.
    Head Neck. 2024 Nov 8. doi: 10.1002/hed.27997.
    

    >> Share

    
    
15. KANG YF, Yang L, Hu YF, Xu K, et al
    Self-Attention Mechanisms-Based Laryngoscopy Image Classification Technique for Laryngeal Cancer Detection.
    Head Neck. 2024 Nov 11. doi: 10.1002/hed.27999.
    

    >> Share

    
    

    
    HNO

16. SCHNELLHARDT S, Tribius S, Linxweiler M, Gostian AO, et al
    [Highlights of the 2024 ASCO Annual Meeting: radiotherapy of head and neck cancer].
    HNO. 2024 Nov 8. doi: 10.1007/s00106-024-01527.
    

    >> Share

    
    

    
    Int J Cancer

17. ABUSAMAK M, Abu-Samak AA, Cai W, Al-Waeli H, et al
    Chronotherapy in head and neck cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35234.
    

    >> Share

    
    

    
    J Laryngol Otol

18. DRANOVA S, Siddiqui Z, Roberts S, Hussa N, et al
    Exploring the Association between Prior Cancer History and Risk of Head and Neck Cancer: Insights from a Multi-Centre Retrospective Case-Control Study.
    J Laryngol Otol. 2024 Nov 11:1-20. doi: 10.1017/S0022215124002251.
    

    >> Share

    
    

    
    J Oral Maxillofac Surg

19. SHIH H, Khanna M, Thomas J, Makhoul NM, et al
    Depth of Invasion Threshold for Recommending Elective Neck Dissection in T1 or T2 Oral Squamous Cell Carcinoma.
    J Oral Maxillofac Surg. 2024 Oct 18:S0278-2391(24)00897.
    

    >> Share

    
    

    
    Laryngoscope

20. DUGUET-ARMAND M, Su J, O'Sullivan B, de Almeida J, et al
    Radiology-Pathology Concordance and Prognostication of Nodal Features in pN+ Oral Cavity Cancer.
    Laryngoscope. 2024;134:4947-4955.
    

    >> Share

    
    
21. PATEL R, Patel AM, Revercomb L, Qie V, et al
    Facility Volume and Changing Facilities for Postoperative Radiotherapy in Salivary Gland Cancer.
    Laryngoscope. 2024;134:4935-4946.
    

    >> Share

    
    
22. LI Y, Shao Y, Sun X, Huang H, et al
    The Transformation of Neck Unicentric Castleman's Disease to Follicular Dendritic Cell Sarcoma.
    Laryngoscope. 2024;134:4985-4987.
    

    >> Share

    
    
23. ZORLU ME, Kertmen C, Aysel A, Yilmaz F, et al
    Use of Cervical Fascia to Prevent Pharyngocutaneus Fistula After Total Laryngectomy.
    Laryngoscope. 2024;134:4964-4970.
    

    >> Share

    
    
24. WOOTTEN CT
    Novel Hyoid Reconstruction and Tracheal Onlay Grafting in a Child with Teratoma and Absence of Hyoid.
    Laryngoscope. 2024;134:5207-5209.
    

    >> Share

    
    
25. NIELSEN US, Rasmussen ER, Rosenorn MR, Schjellerup Jorkov AP, et al
    Recurrent Laryngeal Papillomatosis in Denmark from 1994 to 2021: A Nationwide Register Study.
    Laryngoscope. 2024;134:5047-5053.
    

    >> Share

    
    
26. DUENAS JP, Buitrago-Gomez N, Arias-Botero JH, Randolph G, et al
    The Influence of Impedance on the Efficacy of Radiofrequency Ablation for Benign Thyroid Nodules.
    Laryngoscope. 2024;134:5231-5238.
    

    >> Share

    
    
27. CHEBIB E, Rougier G, Dubray-Vautrin A, Martin J, et al
    Lymph Node Evolution in Eyelid and Orbit Squamous Cell Carcinomas.
    Laryngoscope. 2024;134:4956-4963.
    

    >> Share

    
    

    
    Oral Oncol

28. LI S, Zhao T, Liu N, Li Y, et al
    Global research on oral cancer: A bibliometric analysis based on 82 highly cited publications from 2014 to 2024.
    Oral Oncol. 2024;159:107094.
    

    >> Share

    
    
29. YANG B, Dai X, Li Z, Wu Z, et al
    Noninvasive surface-enhanced Raman spectroscopy outperforms combined positive score in predicting sensitivity to neoadjuvant immunotherapy in head and neck squamous cell carcinoma.
    Oral Oncol. 2024;159:107105.
    

    >> Share

    
    
30. RENGASAMY G, Priya Veeraraghavan V
    Using salivary DNA methylation to predict aging, cell changes, and protein levels for assessing oral mucositis severity and survival in head and neck cancer patients.
    Oral Oncol. 2024;159:107086.
    

    >> Share

    
    
31. LEE YC, Hsin LJ, Lin WN, Fang TJ, et al
    Robot-assisted versus conventional neck dissection in head and neck cancers: A systematic review and meta-analysis.
    Oral Oncol. 2024;159:107101.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

32. DELANEY T, McCarroll L, Ebersole B, Palladino O, et al
    Comparison of Swallowing Measures to Patient-Reported Dysphagia Symptoms in Head and Neck Cancer Patients.
    Otolaryngol Head Neck Surg. 2024 Nov 10. doi: 10.1002/ohn.1047.
    

    >> Share

    
    

    
    PLoS One

33. TANDON A, Sandhya K, Singh NN, Gulati N, et al
    Decoding lymphangiogenesis in oral squamous cell carcinoma: Emphasis on clinical and histopathological determinants of regional metastasis.
    PLoS One. 2024;19:e0311108.
    

    >> Share

    
    

    
    Radiother Oncol

34. DE LEEUW ALMP, Giralt J, Tao Y, Benavente S, et al
    Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer.
    Radiother Oncol. 2024 Nov 8:110612. doi: 10.1016/j.radonc.2024.110612.
    

    >> Share

    
    
35. MALLICK S, Dagar A, Ghosh A, Aashita, et al
    Optimum radiation dose for palliation in head and neck squamous cell carcinoma (OpRAH) - A phase 3 randomized controlled trial.
    Radiother Oncol. 2024 Nov 8:110611. doi: 10.1016/j.radonc.2024.110611.
    

    >> Share

    
    
36. ZHU MY, Wu HJ, Fang T, Zhang GS, et al
    Risk factors of level Ib lymph node metastasis and clinical outcome of its selectively prophylactic irradiation in nasopharyngeal carcinoma: A real-world study.
    Radiother Oncol. 2024 Nov 11:110620. doi: 10.1016/j.radonc.2024.110620.
    

    >> Share

    
    
37. HUANG LW, Pan JW, Li B, Wu WX, et al
    Evaluation of radiation induced brain injury in nasopharyngeal carcinoma patients based on multi-parameter quantitative MRI: A prospective longitudinal study.
    Radiother Oncol. 2024 Nov 11:110621. doi: 10.1016/j.radonc.2024.110621.
    

    >> Share

    
    

    
    Surgery

38. OH MY, Park D, Chai YJ, Kim K, et al
    Transoral robotic thyroidectomy: Lessons learned from consecutive series of 1,000 patients.
    Surgery. 2024 Sep 17:S0039-6060(24)00583-X. doi: 10.1016/j.surg.2024.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share